Showing results (11-20 of 1,526) with videos related to
Sort By:
Pageof 153
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experienceC Richard-Miceli, M DougadosBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Pathophysiology of immune-mediated (type 1) diabetes mellitus: potential for immunotherapyM Abel, M KrokowskiBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Tolerability of aminosalicylates in inflammatory bowel diseaseS Ishaq, J R GreenBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 18, 2001
Gene therapy for muscular dystrophies: current status and future prospectsS Takeda, Y Miyagoe-SuzukiBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 18, 2001
Theoretical basis for the activity of thalidomideC Meierhofer, S Dunzendorfer, C J WiedermannBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
T-cell-activation inhibitors in rheumatoid arthritisHanns-Martin LorenzBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomabBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 6, 2003
Human haemoglobin - NorthfieldBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2003
Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosisDene Simpson, Stuart Noble, Caroline PerryBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 17, 2003
Abetimus: Abetimus sodium, LJP 394Pageof 153